Exhibit 10.4
EXTENSION AGREEMENT
This Agreement, made effective May 29, 1997, by and between AAM Group, Inc.
("AAM") and Biomune Systems, Inc., a Nevada Corporation ("Biomune");
RECITALS
A. An Agreement was made between AAM and Biomune Dated November 25, 1996
("Original Agreement "). The Original Agreement terminated on the 30th day of
March, 1997.
B. The parties hereto desire to continue and extend the consulting
arrangement.
NOW THEREFORE, in consideration of the mutual covenants made herein, the
parties hereto agree as follows:
1. Engagement. The terms and duties of the engagement are the same as
in the Original Agreement
2. Term of the Agreement. The term of AAM's engagement under this
Extension Agreement (the "Term") shall commence on April 1, 1997 (the
"Commencement Date") and shall continue through and expire on the 30th day of
March, 1998 unless sooner terminated by either Biomune or AAM upon thirty (30)
days written notice.
3. Compensation, As compensation for services to be rendered pursuant
to this Extension Agreement, Biomune shall pay AAM 15,000 shares of Biomune
common stock that will be registered pursuant to an S-8 registration
statement.
4. All other terms and conditions contained in the Original Agreement
are incorporated herein.
IN WITNESS WHEREOF, the parties have executed this Extension Agreement
effective as of the date first above-written.
BIOMUNE SYSTEMS, INC.
By: /s/ Xxxxx X. Xxxxxxx
------------------------------------------------
Its: President
AAM GROUP, INC.
By: /s/ Xxxx Kristcher
-----------------------------------------------
Its: President